Serial #79200117
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79200117 Trademark

Serial Number: 79200117 • Registration: 5494415

Serial #79200117 is a trademark filed by Boehringer Ingelheim International GmbH on October 5, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Boehringer Ingelheim International GmbH (4 trademarks)

Binger Strasse 173
Ingelheim 55218 , DE

Entity Type: 03

Trademark Details

Filing Date

October 5, 2016

Registration Date

June 19, 2018

Published for Opposition

April 3, 2018

Cancellation Date

January 3, 2025

Goods & Services

Pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; preparations for health care in the nature of medical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; bacteriological preparations for medical and veterinary use; biological preparations for medical and for veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; biochemical preparations for medical and veterinary purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system and for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders; Chemical preparations for medical purposes for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system, dermatological, hormonal, infectious, viral, immunological and oncological diseases and disorders; ferments for pharmaceutical purposes; vaccines; culture media for cultivating microorganism cells for biotechnological research and manufacturing; plasters and dressings for medical purposes

Scientific and technological services, namely, scientific research, analysis and testing of active substances, medicine and treatments in the fields of biotechnology, development of active medical substances, medicines, pharmaceuticals, and biotechnology; research and development of new products in the field of biotechnology; technical and scientific consultancy in the field of biotechnology; conducting clinical trials for others in the field of pharmaceutical products

Medical and veterinary consulting; providing medical and veterinary information via the Internet; all the aforementioned consultations and services also provided through a database; providing medical information via the Internet

Chemical, biochemical and biological products, substances and preparations, namely, reagents, antibodies, proteins, nucleic acids, fusion proteins, stem cells, and gene therapy preparations for industrial, scientific and research purposes

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 5, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 14, 2026 INTS
INVALIDATION PROCESSED
Feb 14, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 3, 2025 INTR
CANCELLED SECTION 71
Jan 3, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 19, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 19, 2018 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 29, 2018 OPNX
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 14, 2018 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 3, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Mar 30, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 14, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 14, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 14, 2018 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 1, 2018 PREV
ASSIGNED TO LIE
Feb 27, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2018 CNEA
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
Feb 15, 2018 ZZAX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 30, 2018 PBCR
EXPARTE APPEAL TERMINATED
Jan 9, 2018 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 5, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 5, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 5, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 5, 2018 CNEA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 22, 2017 ERFR
EX PARTE APPEAL-INSTITUTED
Dec 22, 2017 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 22, 2017 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Dec 22, 2017 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 22, 2017 GNFN
FINAL REFUSAL E-MAILED
Jun 22, 2017 GNFR
FINAL REFUSAL WRITTEN
Jun 22, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 22, 2017 TCCA
REFUSAL PROCESSED BY IB
Feb 18, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 19, 2017 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jan 19, 2017 RFWR
APPLICATION FILING RECEIPT MAILED
Jan 17, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 14, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jan 13, 2017 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2017 REPR